The haemophilia literature increasingly contains reports describing the use of bypassing agent prophylaxis (BAP) in patients with severe haemophilia A and inhibitors. However, it is difficult to interpret and compare the results and draw conclusions about treatment efficacy because of small patient numbers and a lack of standardization among BAP studies. This article presents consensus recommendations for standardizing future BAP clinical trials developed by an international panel of haemophilia opinion leaders

A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients / J. Teitel, E. Berntorp, G. Dolan, K. Fischer, A. Gringeri, C. Kessler, T. Lambert, C. Leissinger, L. Nemes, M. Shima. - In: HAEMOPHILIA. - ISSN 1351-8216. - 17:3(2011 May), pp. 516-521. [10.1111/j.1365-2516.2010.02440.x]

A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients

A. Gringeri;
2011-05

Abstract

The haemophilia literature increasingly contains reports describing the use of bypassing agent prophylaxis (BAP) in patients with severe haemophilia A and inhibitors. However, it is difficult to interpret and compare the results and draw conclusions about treatment efficacy because of small patient numbers and a lack of standardization among BAP studies. This article presents consensus recommendations for standardizing future BAP clinical trials developed by an international panel of haemophilia opinion leaders
Activated prothrombin complex concentrate; Activated recombinant factor VII; Bypassing therapy; Haemophilia; Inhibitors; Prophylaxis
Settore MED/09 - Medicina Interna
HAEMOPHILIA
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/162462
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact